Cells of origin in cancer - PubMed (original) (raw)
Review
. 2011 Jan 20;469(7330):314-22.
doi: 10.1038/nature09781.
Affiliations
- PMID: 21248838
- DOI: 10.1038/nature09781
Review
Cells of origin in cancer
Jane E Visvader. Nature. 2011.
Abstract
Both solid tumours and leukaemias show considerable histological and functional heterogeneity. It is widely accepted that genetic lesions have a major role in determining tumour phenotype, but evidence is also accumulating that cancers of distinct subtypes within an organ may derive from different 'cells of origin'. These cells acquire the first genetic hit or hits that culminate in the initiation of cancer. The identification of these crucial target cell populations may allow earlier detection of malignancies and better prediction of tumour behaviour, and ultimately may lead to preventive therapies for individuals at high risk of developing cancer.
Similar articles
- Stem-cell origin of metastasis and heterogeneity in solid tumours.
Tu SM, Lin SH, Logothetis CJ. Tu SM, et al. Lancet Oncol. 2002 Aug;3(8):508-13. doi: 10.1016/s1470-2045(02)00820-3. Lancet Oncol. 2002. PMID: 12147437 Review. - Tracing the cellular origin of cancer.
Blanpain C. Blanpain C. Nat Cell Biol. 2013 Feb;15(2):126-34. doi: 10.1038/ncb2657. Epub 2013 Jan 20. Nat Cell Biol. 2013. PMID: 23334500 Review. - Tumour heterogeneity and cancer cell plasticity.
Meacham CE, Morrison SJ. Meacham CE, et al. Nature. 2013 Sep 19;501(7467):328-37. doi: 10.1038/nature12624. Nature. 2013. PMID: 24048065 Free PMC article. Review. - Cancer heterogeneity--a multifaceted view.
De Sousa E Melo F, Vermeulen L, Fessler E, Medema JP. De Sousa E Melo F, et al. EMBO Rep. 2013 Aug;14(8):686-95. doi: 10.1038/embor.2013.92. Epub 2013 Jul 12. EMBO Rep. 2013. PMID: 23846313 Free PMC article. Review. - Stem-cell hierarchy in skin cancer.
Perez-Losada J, Balmain A. Perez-Losada J, et al. Nat Rev Cancer. 2003 Jun;3(6):434-43. doi: 10.1038/nrc1095. Nat Rev Cancer. 2003. PMID: 12778133 Review.
Cited by
- Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations.
Dong X, Zhang D, Zhang X, Liu Y, Liu Y. Dong X, et al. NPJ Syst Biol Appl. 2024 Oct 3;10(1):114. doi: 10.1038/s41540-024-00445-2. NPJ Syst Biol Appl. 2024. PMID: 39362887 Free PMC article. - Nanotechnology based gas delivery system: a "green" strategy for cancer diagnosis and treatment.
Chen M, Xu T, Song L, Sun T, Xu Z, Zhao Y, Du P, Xiong L, Yang Z, Jing J, Shi H. Chen M, et al. Theranostics. 2024 Aug 26;14(14):5461-5491. doi: 10.7150/thno.98884. eCollection 2024. Theranostics. 2024. PMID: 39310098 Free PMC article. Review. - Intricate relationship between cancer stemness, metastasis, and drug resistance.
Dakal TC, Bhushan R, Xu C, Gadi BR, Cameotra SS, Yadav V, Maciaczyk J, Schmidt-Wolf IGH, Kumar A, Sharma A. Dakal TC, et al. MedComm (2020). 2024 Sep 21;5(10):e710. doi: 10.1002/mco2.710. eCollection 2024 Oct. MedComm (2020). 2024. PMID: 39309691 Free PMC article. Review. - Hippo effector, Yorkie, is a tumor suppressor in select Drosophila squamous epithelia.
Bhattacharya R, Kumari J, Banerjee S, Tripathi J, Parihar SS, Mohan N, Sinha P. Bhattacharya R, et al. Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2319666121. doi: 10.1073/pnas.2319666121. Epub 2024 Sep 17. Proc Natl Acad Sci U S A. 2024. PMID: 39288176 - The evolutionary theory of cancer: challenges and potential solutions.
Laplane L, Maley CC. Laplane L, et al. Nat Rev Cancer. 2024 Oct;24(10):718-733. doi: 10.1038/s41568-024-00734-2. Epub 2024 Sep 10. Nat Rev Cancer. 2024. PMID: 39256635 Review.
References
- Lancet. 2010 Jul 24;376(9737):235-44 - PubMed
- Cell. 1990 Aug 24;62(4):697-708 - PubMed
- Science. 2010 Feb 12;327(5967):879-83 - PubMed
- Cancer Cell. 2008 Feb;13(2):129-40 - PubMed
- Methods. 2001 May;24(1):71-80 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources